4 Results for "

Simurosertib

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Simurosertib" in MCE Product Catalog:

13
13 Cited Publications
Cat. No.: HY-100888
CAS No.: 1330782-76-7
Purity:  99.94%
Synonyms: TAK-931
Target:  

CDK

Research Areas:  

Cancer

Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM. Simurosertib has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-100888A
CAS No.: 1330782-69-8
Purity:  99.58%
Synonyms: (R)-TAK-931
Target:  

CDK

Research Areas:  

Others

(R)-Simurosertib ((R)-TAK-931) is the (R)-enantiomer of Simurosertib. Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM .
loading...
    loading...
Cat. No.: HY-100888AR
CAS No.: 1330782-69-8
Target:  

CDK Reference Standards

Research Areas:  

Others

(R)-Simurosertib (Standard) is the analytical standard of (R)-Simurosertib (HY-100888A). This product is intended for research and analytical applications. (R)-Simurosertib ((R)-TAK-931) is the (R)-enantiomer of Simurosertib. Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM .
loading...
    loading...
Cat. No.: HY-100888R
CAS No.: 1330782-76-7
Synonyms: TAK-931 (Standard)
Target:  

CDK Reference Standards

Research Areas:  

Cancer

Simurosertib (Standard) is the analytical standard of Simurosertib (HY-100888). This product is intended for research and analytical applications. Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM. Simurosertib has anti-cancer activity .
loading...
    loading...